source
- Goa Therapeutics launches with $15.5M funding to develop fast-acting alcohol sobering drugGoa Therapeutics announced its launch, backed by $15.5 million raised mainly from individual industry leaders, and has filed for an initial public offering that could raise up to $75 million. The…
- Experts discuss wet AMD treatment limits and need for longer lasting therapiesIn a recent episode of the Denatured podcast, Professor Philip Jacob Rosenfeld of the University of Miami and Wesley Jackson, chief science officer at Valitor, joined host Jennifer C. Smith-Parker…